Drug
Who makes levoleucovorin?
5 companies list levoleucovorin as a human prescription drug, including under the names KHAPZORY. Forms: injection; injection, powder, lyophilized, for solution; injection, solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing levoleucovorin
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Dr. Reddy's Laboratories LimitedIndia | injection, solution | ANDAANDA210892 | 2 | 15 |
| GLAND PHARMA LIMITEDIndia | injection | ANDAANDA210892 | 2 | 4 |
| Hikma Pharmaceuticals USA Inc.United States | injection, powder, lyophilized, for solution | ANDAANDA206263 | 1 | 4 |
| Amneal Ireland LimitedIreland | injection, solution | ANDAANDA207548 | 1 | 1 |
| Acrotech Biopharma Inc | injection, powder, lyophilized, for solution | NDANDA211226 | 1 | 0 |
Orange Book patents
1 unexpired patent lists levoleucovorin as the active ingredient, expiring between Mar 2039 and Mar 2039. Application holder: ACROTECH BIOPHARMA INC.
Enquiry
Common questions
- Who makes levoleucovorin?
- 5 companies list levoleucovorin as a human prescription drug in the openFDA NDC Directory, led by Dr. Reddy's Laboratories Limited, GLAND PHARMA LIMITED, Hikma Pharmaceuticals USA Inc., Amneal Ireland Limited, Acrotech Biopharma Inc. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic KHAPZORY?
- 4 companies list levoleucovorin under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.